glp 1 medications tirzepatide Study Compares GLP-1 Drugs on Their Benefits, Harms news on tirzepatide FDA says

Studies show average weight loss ranging from 10%20% of total body weight when paired with lifestyle changes and professional medical supervision

Additionally, native GLP-1 increases endothelial function and vasodilation in both diabetic and non-diabetic patients, regardless of alterations in insulin sensitivity

Administered 30 minutes before bedtime, sermorelin enhances deep sleep (slow-wave sleep), which is the primary phase of GH release

This triple-agonist approach, targeting GLP-1, GIP, and glucagon receptors, produced the most dramatic weight loss results seen in any Phase 2 obesity trial

We encourage patients to consult with their healthcare provider to fully understand the risks and benefits of compounded medications